Advancements in pharmaceuticals and biologics will continue to impact global market growth through 2025
The global market for aquaculture feed and pharmaceuticals is likely to be influenced by innovations and research in biologics and pharmaceuticals in the coming years. Needless to say, the pharmaceutical and biologics segment will dominate the global aquaculture feed and pharmaceutical market in terms of value during the eight year period 2017 – 2025. Our forecasts indicate that the pharmaceutical and biologics segment will reach a market valuation in excess of US$ 800 Mn by the end of the forecast period, registering an annual growth rate of 7.4%. Advancements in biologics will have a significant impact on the global market, and hence the biologics sub-segment will outpace the other sub-segments in terms of revenue growth, recording an impressive 7.7% CAGR during the forecast period.
The pharmaceutical and biologics segment is expected to be the most lucrative among the product types, with a market attractiveness index of 1.6. The medicated feed segment is expected to be the least attractive product type segment, recording a market attractiveness index of 0.4.
Several factors drive market growth in the pharmaceutical and biologics segment
There is an increasing demand for structured R&D in the niche field of aquaculture feed and pharmaceuticals with research in biologics being a crucial component of the R&D initiatives. This has facilitated faster entry of drugs, medicated feed, and vaccines into the regional markets, specifically in developed countries such as the U.S and Canada. This has fueled inorganic growth in the global aquaculture feed and pharmaceutical market by means of strategic partner selection for M&A initiatives among key players.
The global market for aquaculture feed and pharmaceuticals is also witnessing some key trends. For instance, in the U.S, the usage of extra label drugs is permitted in aquaculture under the guidance and supervision of a licensed veterinarian. The FDA does not object to the use of approved extra label aquaculture medicated feeds if these drugs meet the mandatory compliance conditions stated under the Compliance Policy Guide, 615.115, Extra-label Use of Medicated Feeds for Minor species. This is anticipated to broaden the horizon and scope for further development of medicated feed and pharmaceuticals for aquaculture. Further, an increasing demand for in-feed medication as a prophylactic measure is being witnessed in the global aquaculture feed and pharmaceutical market. There has been a growing adoption of in-feed medication for fish to prevent the large-scale spread of diseases. The main aim here is to medicate healthy fish and prevent any kind of contact with infected fish. The demand for medicated aquafeed is increasing in organized fishing farms across Europe, given the limited use of antibiotics across the region.
Collaborative governmental efforts in R&D augmenting the availability of pharmaceuticals and medicated feed
The governments of various countries are initiating research and development activities in partnership with regulatory bodies in the field of aquaculture feed and pharmaceuticals. This is boosting the availability of quality medicated feed and pharmaceuticals for aquaculture. Aquaculture is becoming an important source of food for human consumption. A rise in the number of organized aquaculture facilities across the globe is influencing the need to develop safe and effective drugs to treat various types of diseases in fish.
Lack of harmonization of veterinary medicinal products and medicated feed restricting market growth over the forecast period
In developed regions such as the EU, different laws have been defined for manufacturing veterinary medicines and medicated feed. For example in Germany, totally separated production lines have to be installed for compound feed and medicated feed. Further, the level of residue of veterinary medicines allowed in feed is different across different countries. This hampers market estimation and forecast.
An Introduction to the Report
Persistence Market Research analysts have studied the global aquaculture feed and pharmaceutical market in depth over an eight year forecast period 2017 – 2025. In a new publication titled ‘Aquaculture Feed and Pharmaceutical Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ we present key insights into the global aquaculture feed and pharmaceutical market including the trends and opportunities likely to emerge in the global market during the forecast period. Our report presents a structured forecast of the global aquaculture feed and pharmaceutical market based on various segments that are studied across the key assessed geographies.
Our report on the global aquaculture feed and pharmaceutical market begins with an executive summary that is a gist of the entire report, highlighting the key takeaways. The executive summary comprises the market overview, our analysis of the global aquaculture feed and pharmaceutical market, and recommendations to key market players. This is followed by the market introduction that defines the global aquaculture feed and pharmaceutical market and presents the market taxonomy. The market view point comes next, where we track the market scenario with key inferences drawn from historical data, current trends, and future prospects. This section comprises our analysis of the macro-economic factors impacting the global aquaculture feed and pharmaceutical market as well as an opportunity analysis.
The next few sections trace the evolution of the global aquaculture feed and pharmaceutical market across the different geographies and present forecasts of the different regional markets based on the market segmentation. These sections provide detailed insights into the regional market dynamics (drivers, restraints, trends) and present the historical as well as current market size for the various segments. An impact analysis of the drivers and restraints followed by a regional market attractiveness analysis and information on key market participants concludes these sections. The last few sections pertain to the relevance and impact of the different forecast factors on the global aquaculture feed and pharmaceutical market followed by the forecast assumptions, which is a glossary of assumptions and acronyms used throughout the report.
One of the most important sections of the report is the competitive landscape, which features some of the leading players operating in the global aquaculture feed and pharmaceutical market. The highlight of this section are the profiles of some of the key market players, with a specific focus on their business and product strategy. This section is intended to present a dashboard view of the leading companies operating in the global aquaculture feed and pharmaceutical market and will help readers acquire an overview of the competitive landscape of the global market. The market structure, a competition intensity mapping by market taxonomy, and a competition dashboard comprise this section.
The report ends with the global aquaculture feed and pharmaceutical market analysis and forecast in terms of both historical and current market size for the various segments and regions. Key trends and developments in the global market are also tracked in this section, and a global market attractiveness analysis is presented for the benefit of the reader. Some of the key metrics readers can hope to find here include Y-o-Y growth and absolute dollar opportunity.
To estimate the market numbers for the global aquaculture feed and pharmaceutical market, we have leveraged Persistence Market Research’s tried and tested research methodology that factors in extensive primary and secondary research and validates this data using the triangulation method to arrive at the final data points. This data is then scrutinized using advanced tools to garner qualitative and quantitative insights into the global aquaculture feed and pharmaceutical market. By following this multi-data multi-scrutiny process, we provide relevant market insights that are backed by near 100% accurate data and supported by the expert analysis of our team of researchers in the healthcare domain.